OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies
Lena Allweiss, Annika Volmari, Vithika Suri, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 882-891
Open Access | Times Cited: 18

Showing 18 citing articles:

Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome
Fabien Zoulim, Pei‐Jer Chen, Maura Dandri, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 1087-1099
Open Access | Times Cited: 16

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg‐IFNα‐2a as Treatment for Chronic Hepatitis Delta
Pietro Lampertico, Pavel Bogomolov, Vladimir Chulanov, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access

Drug development for chronic hepatitis B functional cure: Recent progress
Ting Liu, He Wang, Yue Zhao, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 4
Closed Access

Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide
Pierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. 819-826
Closed Access | Times Cited: 3

SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential
John Bacher, Lena Allweiss, Maura Dandri
Viruses (2024) Vol. 16, Iss. 11, pp. 1667-1667
Open Access | Times Cited: 3

Antiviral therapy for chronic hepatitis delta: new insights from clinical trials and real-life studies
Pietro Lampertico, Maria Paola Anolli, Dominique Roulot, et al.
Gut (2024), pp. gutjnl-332597
Closed Access | Times Cited: 2

The Changing Face of Hepatitis Delta Virus Associated Hepatocellular Carcinoma
Mariana Cardoso, Mariana Verdelho Machado
Cancers (2024) Vol. 16, Iss. 22, pp. 3723-3723
Open Access | Times Cited: 1

Advances in hepatitis delta research: emerging insights and future directions
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Sexually Transmitted Infections (2024) Vol. 100, Iss. 5, pp. 310-317
Closed Access

Bulevirtide monotherapy in patients with chronic HDV needs further evaluation
Jianing Li, Guoli Xing, Ying Tong
Journal of Hepatology (2024)
Closed Access

Chronic Hepatitis D Virus Infection and Its Treatment: A Narrative Review
Poonam Mathur, Arshi Khanam, Shyam Kottilil
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2177-2177
Open Access

Hepatitis D Virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells
Jan‐Hendrik Bockmann, Lena Allweiss, Annika Volmari, et al.
JHEP Reports (2024) Vol. 7, Iss. 3, pp. 101273-101273
Open Access

The regulatory role of Epinephelus Coioides miR-21 in the Infection and Replication of Iridovirus SGIV
Wei Huang, Pin-Hong Li, Ran He, et al.
Virology (2024) Vol. 603, pp. 110325-110325
Closed Access

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
Pavel Bogomolov, N.A. Shub, N. A. Gasilova, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2024) Vol. 34, Iss. 5, pp. 40-46
Open Access

Page 1

Scroll to top